GlassScriptPhysician profile
Blaise M Kovaz
NPI 1174505341
$990.72
in general payments reported to CMS, 2019-2025
18 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.45 · 2020: $223 · 2021: $222 · 2022: $73.70 · 2023: $81.50 · 2024: $92.94 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $210.20 | 2019-2025 | Aptima |
| Dysis Medical, INC. | $179.83 | 2020 | |
| Pfizer INC. | $178.46 | 2019-2024 | |
| Astellas Pharma US INC | $90.36 | 2019-2025 | Veozah |
| Abbvie INC. | $57.65 | 2021 | |
| Baxter Healthcare | $57.01 | 2021-2025 | Perclot |
| Merck Sharp & Dohme LLC | $41.79 | 2022 | |
| Channel Medsystems, INC. | $29.70 | 2023 | |
| Biogen, INC. | $22.98 | 2025 | Zurzuvae |
| Amgen INC. | $18.43 | 2025 | Evenity |
| Millicent US INC | $17.90 | 2024 | Intrarosa, Femring |
| Allergan, INC. | $17.77 | 2019 | |
| Evofem Biosciences, INC. | $14.47 | 2022 | |
| Caldera Medical, INC | $14.15 | 2021 | |
| Exeltis, USA INC. | $14.03 | 2025 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $13.84 | 2021 | |
| Coopersurgical, INC. | $12.15 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaise Kovaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.